|
38 Companies |
|
50 Products |
|
50 Products |
|
51 Mechanisms of Action |
|
3 Trials |
|
1810 News |
|
| «12345678910111213...3132» |
- | galantamine extended release / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Effect of Galantamine on Short-term Abstinence (clinicaltrials.gov) - Apr 6, 2018
P2, N=98, Completed, Sponsor: University of Pennsylvania
Recruiting --> Completed | Trial completion date: Mar 2018 --> Nov 2017 | Trial primary completion date: Feb 2018 --> Nov 2017
- | Phase classification: Effect of Lung Cancer Diagnoses on Family Behaviors (clinicaltrials.gov) - Apr 5, 2018
P, N=507, Completed, Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting --> Completed | Trial completion date: Mar 2018 --> Nov 2017 | Trial primary completion date: Feb 2018 --> Nov 2017 Phase classification: P=N/A --> P
- | FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion, Phase classification, Enrollment change: Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers (clinicaltrials.gov) - Apr 4, 2018
P, N=62, Completed, Sponsor: University of North Carolina, Chapel Hill
Phase classification: P=N/A --> P Recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 62
- | Trial completion: Project 2: Strategies for Reducing Nicotine Content in Cigarettes (clinicaltrials.gov) - Mar 27, 2018
P3, N=1250, Completed, Sponsor: Wake Forest University Health Sciences
Recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 62 Active, not recruiting --> Completed
- | Trial completion: Novel Methods to Reduce Children's Secondhand Smoke Exposure II (clinicaltrials.gov) - Mar 15, 2018
P=N/A, N=74, Completed, Sponsor: University of Oklahoma
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Phase classification: Phone-Based Postpartum Continuing Care for Smoking Cessation (clinicaltrials.gov) - Mar 13, 2018
P=N/A, N=130, Completed, Sponsor: Battelle Memorial Institute
Active, not recruiting --> Completed Phase classification: P1/2 --> P=N/A
- | bupropion sustained-release / Generic mfg.
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: CPT and Smoking Cessation (clinicaltrials.gov) - Mar 9, 2018
P2/3, N=69, Completed, Sponsor: VA Office of Research and Development
Phase classification: P1/2 --> P=N/A Active, not recruiting --> Completed | N=50 --> 69 | Trial completion date: Apr 2018 --> Jul 2017 | Trial primary completion date: Apr 2018 --> Jul 2017
- |||| Chantix (varenicline) / Pfizer
Trial completion: Smoking Cessation Study In Healthy Adolescent Smokers (clinicaltrials.gov) - Feb 19, 2018
P4, N=313, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed | N=50 --> 69 | Trial completion date: Apr 2018 --> Jul 2017 | Trial primary completion date: Apr 2018 --> Jul 2017 Active, not recruiting --> Completed
- | Chantix (varenicline) / Pfizer
Trial completion, Trial primary completion date: The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior (clinicaltrials.gov) - Feb 8, 2018
P2, N=62, Completed, Sponsor: Yale University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jul 2016 --> Oct 2016
- | Chantix (varenicline) / Pfizer
Trial completion, Enrollment change, Trial primary completion date: Do Treatments for Smoking Cessation Affect Alcohol Drinking? (clinicaltrials.gov) - Feb 7, 2018
P2, N=60, Completed, Sponsor: Yale University
Active, not recruiting --> Completed | Trial primary completion date: Jul 2016 --> Oct 2016 Active, not recruiting --> Completed | N=308 --> 60 | Trial primary completion date: Dec 2017 --> Nov 2016
- | Enrollment change, Trial primary completion date: Smokers' Response to Nicotine Dependence Genotyping (clinicaltrials.gov) - Feb 1, 2018
P=N/A, N=24, Completed, Sponsor: University of Nebraska
Active, not recruiting --> Completed | N=308 --> 60 | Trial primary completion date: Dec 2017 --> Nov 2016 N=150 --> 24 | Trial primary completion date: May 2013 --> Aug 2013
- | Trial completion: Mobile Mindfulness Training for Smoking Cessation (clinicaltrials.gov) - Jan 30, 2018
P=N/A, N=1251, Completed, Sponsor: University of Massachusetts, Worcester
N=150 --> 24 | Trial primary completion date: May 2013 --> Aug 2013 Active, not recruiting --> Completed
- | Trial completion, Enrollment change: Adolescent Smoking Cessation in Pediatric Primary Care (clinicaltrials.gov) - Jan 18, 2018
P=N/A, N=10967, Completed, Sponsor: American Academy of Pediatrics
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=8160 --> 10967
- | Chantix (varenicline) / Pfizer
Phase classification: Donaghue: Contingency Management and Pharmacotherapy for Smoking Cessation (clinicaltrials.gov) - Jan 16, 2018
P=N/A, N=59, Completed, Sponsor: UConn Health
Active, not recruiting --> Completed | N=8160 --> 10967 Phase classification: P2 --> P=N/A
- | Trial primary completion date: Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status (clinicaltrials.gov) - Jan 5, 2018
P=N/A, N=400, Active, not recruiting, Sponsor: Milton S. Hershey Medical Center
Phase classification: P2 --> P=N/A Trial primary completion date: Oct 2017 --> Mar 2018
- | Enrollment change, Trial termination, Trial primary completion date: Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients (clinicaltrials.gov) - Jan 4, 2018
P4, N=7, Terminated, Sponsor: University of Cincinnati
Trial primary completion date: Oct 2017 --> Mar 2018 N=20 --> 7 | Enrolling by invitation --> Terminated | Trial primary completion date: Mar 2018 --> Aug 2017; Difficulty recruiting eligible participants; study medication was expiring.
- | Trial primary completion date: BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit (clinicaltrials.gov) - Jan 3, 2018
P=N/A, N=331, Active, not recruiting, Sponsor: Duke University
N=20 --> 7 | Enrolling by invitation --> Terminated | Trial primary completion date: Mar 2018 --> Aug 2017; Difficulty recruiting eligible participants; study medication was expiring. Trial primary completion date: Nov 2017 --> Mar 2018
- | Trial initiation date: Smoking-induced EGF-dependent Reprogramming of Airway Basal Cell Function (clinicaltrials.gov) - Dec 26, 2017
P=N/A, N=48, Terminated, Sponsor: Weill Medical College of Cornell University
Trial primary completion date: Nov 2017 --> Mar 2018 Initiation date: Jun 2013 --> Dec 2013
- | Phase classification: Smoking Cessation for Smokers With Sleep Problems (clinicaltrials.gov) - Dec 21, 2017
P=N/A, N=19, Completed, Sponsor: Yale University
Initiation date: Jun 2013 --> Dec 2013 Phase classification: P1 --> P=N/A
- | doxazosin mesylate / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes? (clinicaltrials.gov) - Dec 20, 2017
P2, N=35, Completed, Sponsor: Yale University
Phase classification: P1 --> P=N/A Active, not recruiting --> Completed | N=60 --> 35 | Trial primary completion date: Dec 2017 --> Nov 2016
- | naltrexone / Generic mfg.
New P2 trial, Combination therapy: Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana (clinicaltrials.gov) - Dec 19, 2017
P2, N=49, Completed, Sponsor: New York State Psychiatric Institute
- | naltrexone / Generic mfg.
Trial completion, Combination therapy: Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana (clinicaltrials.gov) - Dec 19, 2017
P2, N=49, Completed, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed | N=60 --> 35 | Trial primary completion date: Dec 2017 --> Nov 2016 Not yet recruiting --> Completed
- | Enrollment change: ECIG: Effects of Electronic Cigarettes on Nicotine Concentrations (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=27, Completed, Sponsor: UConn Health
Not yet recruiting --> Completed N=20 --> 27
- | Chantix (varenicline) / Pfizer
Trial completion, Enrollment change, Trial primary completion date: Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors (clinicaltrials.gov) - Dec 19, 2017
P4, N=93, Completed, Sponsor: Nathan Kline Institute for Psychiatric Research
N=20 --> 27 Recruiting --> Completed | N=60 --> 93 | Trial primary completion date: Dec 2012 --> Dec 2013
- | Trial completion, Enrollment change, Trial primary completion date: Curbing Tobacco Use in Suburban and Rural Schools (clinicaltrials.gov) - Nov 6, 2017
P1, N=1289, Completed, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed | N=60 --> 93 | Trial primary completion date: Dec 2012 --> Dec 2013 Active, not recruiting --> Completed | N=2384 --> 1289 | Trial primary completion date: Jan 2019 --> Oct 2017
- | Trial completion: Early Detection of and Intervention Towards Chronic Diseases Among Individuals Without Formal Education (clinicaltrials.gov) - Nov 6, 2017
P=N/A, N=1047, Completed, Sponsor: University of Southern Denmark
Active, not recruiting --> Completed | N=2384 --> 1289 | Trial primary completion date: Jan 2019 --> Oct 2017 Active, not recruiting --> Completed
- | Chantix (varenicline) / Pfizer
Trial completion, Trial primary completion date: Exercise or Relaxation for Smoking Cessation (clinicaltrials.gov) - Oct 31, 2017
P=N/A, N=301, Completed, Sponsor: UConn Health
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Aug 2017
- | Trial completion: Abstinence Reinforcement Therapy (ART) for Rural Veteran Smokers (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=300, Completed, Sponsor: VA Office of Research and Development
Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Aug 2017 Active, not recruiting --> Completed
- | Trial completion, HEOR: Medical Marijuana Use in HIV+ Patients Prospective Cohort Study (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=150, Completed, Sponsor: Wayne State University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Examining Yoga's Effects on Smoking (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=50, Completed, Sponsor: University of Texas at Austin
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment change: Anodal Transcranial Direct Current Stimulation (tDCS) in the Treatment of Tobacco Addiction (clinicaltrials.gov) - Oct 24, 2017
P=N/A, N=38, Completed, Sponsor: H
Active, not recruiting --> Completed N=25 --> 38
- | Trial completion, Enrollment change: Countering Young Adult Tobacco Marketing in Bars (clinicaltrials.gov) - Oct 18, 2017
P=N/A, N=17422, Completed, Sponsor: University of California, San Francisco
N=25 --> 38 Active, not recruiting --> Completed | N=25200 --> 17422
- | Trial completion, Trial primary completion date: Intensive Smoking-cessation Intervention Versus Smoking-cessation Advice in Smear-positive Patients With Pulmonary Tuberculosis (clinicaltrials.gov) - Oct 13, 2017
P3, N=800, Completed, Sponsor: All India Institute of Medical Sciences, New Delhi
Active, not recruiting --> Completed | N=25200 --> 17422 Active, not recruiting --> Completed | Trial primary completion date: Feb 2016 --> Sep 2016
- | Trial primary completion date: BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit (clinicaltrials.gov) - Oct 13, 2017
P=N/A, N=331, Active, not recruiting, Sponsor: Duke University
Active, not recruiting --> Completed | Trial primary completion date: Feb 2016 --> Sep 2016 Trial primary completion date: Aug 2017 --> Nov 2017
- | Trial completion: Nicotine Metabolism and Little Cigars (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=197, Completed, Sponsor: University of Pennsylvania
Trial primary completion date: Aug 2017 --> Nov 2017 Active, not recruiting --> Completed
- | Enrollment closed, Enrollment change: Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy (clinicaltrials.gov) - Oct 6, 2017
P1, N=60, Active, not recruiting, Sponsor: Wayne State University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=80 --> 60
- | Enrollment closed, Trial initiation date, Trial primary completion date: Videogame-based Incentives for Smoking Cessation (clinicaltrials.gov) - Sep 28, 2017
P=N/A, N=100, Active, not recruiting, Sponsor: Rowan University
Recruiting --> Active, not recruiting | N=80 --> 60 Not yet recruiting --> Active, not recruiting | Initiation date: Dec 2015 --> May 2017 | Trial primary completion date: Jul 2016 --> Jul 2018
- | Trial completion: Emerging Adults Who Use Alcohol and Marijuana (clinicaltrials.gov) - Sep 18, 2017
P3, N=566, Completed, Sponsor: Butler Hospital
Not yet recruiting --> Active, not recruiting | Initiation date: Dec 2015 --> May 2017 | Trial primary completion date: Jul 2016 --> Jul 2018 Active, not recruiting --> Completed
- ||| Chantix (varenicline) / Pfizer
Trial initiation date: Understanding Disparities in Quitting in African American and White Smokers (clinicaltrials.gov) - Aug 31, 2017
P4, N=449, Completed, Sponsor: Nikki Nollen, PhD, MA
Active, not recruiting --> Completed Initiation date: Jun 2012 --> Feb 2013
- | Phase classification: PRIDE: Preventing Respiratory Illnesses During Childhood Study (clinicaltrials.gov) - Aug 24, 2017
P=N/A, N=350, Completed, Sponsor: Johns Hopkins University
Initiation date: Jun 2012 --> Feb 2013 Phase classification: P4 --> P=N/A
- | Trial primary completion date: Computer-Assisted Counseling in Helping African American Smokers Stop Smoking (clinicaltrials.gov) - Aug 22, 2017
P=N/A, N=462, Completed, Sponsor: M.D. Anderson Cancer Center
Phase classification: P4 --> P=N/A Trial primary completion date: Aug 2016 --> Aug 2006
- | Trial primary completion date: Web and Mobile Smoking Cessation (clinicaltrials.gov) - Aug 22, 2017
P=N/A, N=1266, Active, not recruiting, Sponsor: Oregon Research Institute
Trial primary completion date: Aug 2016 --> Aug 2006 Trial primary completion date: Jun 2017 --> Oct 2017
- | Chantix (varenicline) / Pfizer
Enrollment change, Adherence: Improving Adherence to Smoking Cessation Medication Among PLWHA (clinicaltrials.gov) - Aug 18, 2017
P=N/A, N=158, Completed, Sponsor: New York University School of Medicine
Trial primary completion date: Jun 2017 --> Oct 2017 N=114 --> 158
- | Chantix (varenicline) / Pfizer
Enrollment change: Effects of Varenicline on Smoking Reminders (clinicaltrials.gov) - Aug 17, 2017
P2, N=124, Completed, Sponsor: University of Pennsylvania
N=114 --> 158 N=62 --> 124
- | topiramate / Generic mfg.
Enrollment change, Combination therapy: Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study (clinicaltrials.gov) - Aug 16, 2017
P3, N=57, Completed, Sponsor: UConn Health
N=62 --> 124 N=84 --> 57
- | Trial completion, Enrollment change: GESTABAC: Effectiveness of an Intervention in Primary Care to Promote Smoking Cessation in Pregnant Women (clinicaltrials.gov) - Aug 7, 2017
P=N/A, N=350, Completed, Sponsor: Gerencia de Atenci
N=84 --> 57 Active, not recruiting --> Completed | N=600 --> 350
- | Trial completion, Phase classification, Enrollment change, Trial primary completion date: Quit Smoking With Nicotine Patch and Exercise/Health Education (Females Only) (clinicaltrials.gov) - Aug 1, 2017
P=N/A, N=113, Completed, Sponsor: Brown University
Active, not recruiting --> Completed | N=600 --> 350 Recruiting --> Completed | Phase classification: P2 --> PN/A | N=164 --> 113 | Trial primary completion date: Jan 2016 --> Jul 2017
- | Chantix (varenicline) / Pfizer
Trial completion, Phase classification, Enrollment change: Extended Treatment for Smoking Cessation (clinicaltrials.gov) - Aug 1, 2017
P4, N=223, Completed, Sponsor: Stanford University
Recruiting --> Completed | Phase classification: P2 --> PN/A | N=164 --> 113 | Trial primary completion date: Jan 2016 --> Jul 2017 Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | N=400 --> 223
- | Trial completion, Trial primary completion date: Not Quite Ready to Quit (clinicaltrials.gov) - Jul 31, 2017
P=N/A, N=560, Completed, Sponsor: University of Vermont
Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | N=400 --> 223 Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Jan 2015
- | Trial primary completion date: Intranasal Insulin for Weight Management During Smoking Cessation (clinicaltrials.gov) - Jul 28, 2017
P2, N=40, Recruiting, Sponsor: Ajna Hamidovic
Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Jan 2015 Trial primary completion date: Feb 2016 --> Jul 2016